{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:48:11Z","timestamp":1771339691747,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.intimp.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T15:51:24Z","timestamp":1445701884000},"page":"494-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["HDAC expression and activity is upregulated in diseased lupus-prone mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Nicole L.","family":"Regna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda D.","family":"Vieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"Gojmerac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin M.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Caudell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4787-7750","authenticated-orcid":false,"given":"Christopher M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.intimp.2015.10.006_bb0005","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/ar1009","article-title":"B cell abnormalities in systemic lupus erythematosus","volume":"5","author":"Grammer","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2015.10.006_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2009.12.005","article-title":"Pathogenesis of human systemic lupus erythematosus: recent advances","volume":"16","author":"Crispin","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","article-title":"Pathogenesis of systemic lupus erythematosus","volume":"56","author":"Mok","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/ar3433","article-title":"Mechanisms of B cell autoimmunity in SLE","volume":"13","author":"Dorner","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2015.10.006_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ki.1973.15","article-title":"Immune complex systems in the nephritis of systemic lupus erythematosus","volume":"3","author":"Agnello","year":"1973","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2015.10.006_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2006.06.005","article-title":"Regulatory T cells in patients with systemic lupus erythematosus","volume":"27","author":"Alvarado-Sanchez","year":"2006","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2015.10.006_bb0040","doi-asserted-by":"crossref","first-page":"980286","DOI":"10.1155\/2011\/980286","article-title":"Th subset balance in lupus nephritis","volume":"2011","author":"Miyake","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0045","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2119\/molmed.2011.00055","article-title":"HDAC inhibition in lupus models","volume":"17","author":"Reilly","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2119\/molmed.2011.00116","article-title":"Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer","volume":"17","author":"Dinarello","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0055","first-page":"462","article-title":"Histone deacetylase inhibitors in the treatment of lymphoma","volume":"10","author":"Lemoine","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","article-title":"HDAC family: what are the cancer relevant targets?","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2015.10.006_bb0065","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.gastro.2009.10.037","article-title":"Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice","volume":"138","author":"de Zoeten","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2015.10.006_bb0070","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","article-title":"Deacetylase inhibition promotes the generation and function of regulatory T cells","volume":"13","author":"Tao","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0075","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/MCB.05155-11","article-title":"Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells","volume":"31","author":"de Zoeten","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0080","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.4049\/jimmunol.173.6.4171","article-title":"Modulation of renal disease in MRL\/lpr mice by suberoylanilide hydroxamic acid","volume":"173","author":"Reilly","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13148-010-0012-4","article-title":"Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy","volume":"1","author":"Wagner","year":"2010","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.intimp.2015.10.006_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2004.10.024","article-title":"Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis","volume":"119","author":"Vega","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2015.10.006_bb0095","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","article-title":"Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development","volume":"24","author":"Chang","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","article-title":"Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10","volume":"126","author":"Chang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2015.10.006_bb0105","doi-asserted-by":"crossref","first-page":"28833","DOI":"10.1074\/jbc.M111.233932","article-title":"Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity","volume":"286","author":"Yan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2015.10.006_bb0110","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-3-642-21631-2_6","article-title":"Rationale for HDAC inhibitor therapy in autoimmunity and transplantation","volume":"206","author":"Hancock","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0120","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2008-03-143644","article-title":"HDAC6 inhibition enhances 17-AAG\u2013mediated abrogation of hsp90 chaperone function in human leukemia cells","volume":"112","author":"Rao","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2015.10.006_bb0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2015.10.006_bb0130","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"The Oncologist"},{"key":"10.1016\/j.intimp.2015.10.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/cmi.2010.1","article-title":"Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL\/lpr mouse mesangial cells","author":"Peairs","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2014.01.002","article-title":"Class I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo","volume":"151","author":"Regna","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0145","doi-asserted-by":"crossref","first-page":"271694","DOI":"10.1155\/2011\/271694","article-title":"Murine models of systemic lupus erythematosus","volume":"2011","author":"Perry","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0150","first-page":"728605","article-title":"Role of hsp90 in systemic lupus erythematosus and its clinical relevance","volume":"2012","author":"Shukla","year":"2012","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.intimp.2015.10.006_bb0155","doi-asserted-by":"crossref","first-page":"ra45","DOI":"10.1126\/scisignal.2002873","article-title":"Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms","volume":"5","author":"Beier","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2015.10.006_bb0160","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2011.07.002","article-title":"Histone\/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells","volume":"23","author":"Beier","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","article-title":"T cells as therapeutic targets in SLE","volume":"6","author":"Crispin","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0170","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/rheumatology\/kel029","article-title":"Imbalance of Th1\/Th2 transcription factors in patients with lupus nephritis","volume":"45","author":"Chan","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2015.10.006_bb0175","doi-asserted-by":"crossref","first-page":"823085","DOI":"10.1155\/2012\/823085","article-title":"Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new","volume":"2012","author":"Alunno","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2015.10.006_bb0185","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/srep00220","article-title":"Histone deacetylase inhibitors globally enhance h3\/h4 tail acetylation without affecting h3 lysine 56 acetylation","volume":"2","author":"Drogaris","year":"2012","journal-title":"Sci. Report."},{"key":"10.1016\/j.intimp.2015.10.006_bb0190","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00086.2009","article-title":"Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury","volume":"297","author":"Noh","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0195","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/ki.1996.229","article-title":"Roles of the mesangium in glomerular function","volume":"49","author":"Schlondorff","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2015.10.006_bb0200","doi-asserted-by":"crossref","first-page":"430239","DOI":"10.1155\/2013\/430239","article-title":"MicroRNAs implicated in the immunopathogenesis of lupus nephritis","volume":"2013","author":"Chafin","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0205","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1523-1755.2002.00230.x","article-title":"Modulation of renal disease in MRL\/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase","volume":"61","author":"Reilly","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2015.10.006_bb0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00011-009-7215-1","article-title":"Widespread expression of inducible NOS and citrulline in lupus nephritis tissues","volume":"58","author":"Bollain-y-Goytia","year":"2009","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2015.10.006_bb0215","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2249.2009.03924.x","article-title":"Activation of AMPK inhibits inflammation in MRL\/lpr mouse mesangial cells","volume":"156","author":"Peairs","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0220","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4049\/jimmunol.1302112","article-title":"Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus","volume":"192","author":"Palanichamy","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0225","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1074\/jbc.M109861200","article-title":"Molecular cloning and characterization of a novel histone deacetylase HDAC10","volume":"277","author":"Guardiola","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2015.10.006_bb0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1074\/jbc.M108931200","article-title":"Isolation and characterization of mammalian HDAC10, a novel histone deacetylase","volume":"277","author":"Kao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2015.10.006_bb0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar2511","article-title":"Regulatory T cells in systemic lupus erythematosus: past, present and future","volume":"10","author":"Horwitz","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2015.10.006_bb0240","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-02-207118","article-title":"Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization","volume":"115","author":"van Loosdregt","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2015.10.006_bb0245","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/art.23464","article-title":"Function of CD4+,CD25+ Treg cells in MRL\/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells","volume":"58","author":"Parietti","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2015.10.006_bb0250","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/kes058","article-title":"CD4(+)CD25(+) regulatory T cells from MRL\/lpr mice were functionally more active in vitro but did not prevent spontaneous as well as adriamycin-induced nephropathy in vivo","volume":"51","author":"Kim","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2015.10.006_bb0255","first-page":"235","article-title":"Treatment of lupus nephritis: facing the era of immunotherapy","volume":"50","author":"Aran","year":"2008","journal-title":"Panminerva Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0260","doi-asserted-by":"crossref","first-page":"139365","DOI":"10.1155\/2012\/139365","article-title":"Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown","volume":"2012","author":"Yung","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0265","doi-asserted-by":"crossref","first-page":"953","DOI":"10.5301\/jn.5000272","article-title":"NF-kappaB and systemic lupus erythematosus: examining the link","volume":"26","author":"Zubair","year":"2013","journal-title":"J. Nephrol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0270","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00011-012-0442-x","article-title":"HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor-kappaB pathways","volume":"61","author":"Shimp","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2015.10.006_bb0275","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5301\/JN.2011.8451","article-title":"Increased apoptosis and expression of FasL, Bax and caspase-3 in human lupus nephritis class II and IV","volume":"25","author":"Cui","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0280","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.cdd.4400724","article-title":"Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus","volume":"7","author":"Graninger","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2015.10.006_bb0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.it.2011.04.001","article-title":"Histone deacetylases as regulators of inflammation and immunity","volume":"32","author":"Shakespear","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0290","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2119\/molmed.2011.00021","article-title":"Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus","volume":"17","author":"Christensen","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0295","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.2010.08342.x","article-title":"The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism","volume":"151","author":"Buglio","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2015.10.006_bb0300","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1038\/ncomms7838","article-title":"Manipulation of B-cell responses with histone deacetylase inhibitors","volume":"6","author":"Waibel","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2015.10.006_bb0305","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","article-title":"Long-term prognosis and causes of death in systemic lupus erythematosus","volume":"119","author":"Doria","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2015.10.006_bb0310","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol. Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915301399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576915301399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T06:59:02Z","timestamp":1537253942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576915301399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1567576915301399"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.10.006","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC expression and activity is upregulated in diseased lupus-prone mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}